Astrazeneca Pharma India Ltd.

ASTRAZEN

₹7172.6

3.36% (232.95)

Market Cap

₹17,933 Cr.

P/E

111.03

About

AstraZeneca Pharma India Limited (AZPIL) operates as a subsidiary of AstraZeneca Plc, UK, and is dedicated to providing life-changing medicines through innovative science. The company focuses on areas… Read more

AstraZeneca Pharma India Limited (AZPIL) operates as a subsidiary of AstraZeneca Plc, UK, and … Read more

Low

3750

52W Range

High

7572

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

22.69%

3yr Average

17.2%

5yr Average

18.37%

Net Profit Margin

Latest

12.47%

3yr Average

10.0%

5yr Average

10.03%

ROCE

Latest

25.23%

3yr Average

22.06%

5yr Average

23.99%

Debt to Equity

Latest

3yr Average

0.0

5yr Average

0.0

Market Share

1.42 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

1.71 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.56 %

(as of May 19)

Historic

Blood Related - Market Share

1.73 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.94 %

(as of Nov 21)

Historic

Endocrinology - Market Share

0 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.45 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.11 %

(as of Nov 21)

Historic

Respiratory - Market Share

1.96 %

(as of May 19)

Historic

Stomatological - Market Share

0 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Dosage Form Break-Up

Brand Wise Break-Up - Oncology

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Crestor

Suppliers

Piramal Enterprises Ltd.
Cigniti Technologies Ltd.
Gulshan Polyols Ltd.
Take Solutions Ltd.
Vivimed Labs Ltd.

FAQs on Astrazeneca Pharma India Ltd. Business

What does Astrazeneca Pharma I do?

AstraZeneca Pharma India, a subsidiary of AstraZeneca Plc, focuses on delivering innovative medicines in cardiovascular, renal, metabolic diseases, oncology, and respiratory therapies.

Who are the competitors of Astrazeneca Pharma I?

Astrazeneca Pharma I major competitors are Sanofi India, Eris Lifesciences, Wockhardt, Jubilant Pharmova, Caplin Point Lab, Alembic Pharma, Natco Pharma.
Market Cap of Astrazeneca Pharma I is ₹17,933 Crs.
While the median market cap of its peers are ₹14,602 Crs.

Is Astrazeneca Pharma I financially stable compared to its peers?

Astrazeneca Pharma I seems to be financially stable compared to its peers.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate peers.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec